Analytical Challenges for Biological Drug Substances and Products - This conference is part of PharmaLab 2019

Analytical Challenges for Biological Drug Substances and Products - This conference is part of PharmaLab 2019

Düsseldorf/Neuss, Germany

Course No 200038


Costs

: EUR 590,--

(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Programme

Description of analytical procedure and validation, a regulator's view
Luka Kosec, JAZMP - Slovenian medicinal Agency

How to overcome some of the challenges when analysing Biological Drug Substances and Products
Thomas Fechner, Agilent

Analytical Quality by Design Through the Lifecycle
Patrick Jackson, GSK

State-of-the-Art evaluation of potency bioassays
Klemens Weitenthaler, VelaLabs – A Tentamus Company

Process for automatization of a Bioassay
Dr Marcus Gutmann, Microcoat Biotechnologie


Application of fast and non-destructive analysis techniques in quality and in-process control
Prof. Dr. Hartwig Schulz, formerly Julius Kühn-Institut (JKI)

Lectin Array – a novel technology for investigation of pharmaceutical products
Markus Roucka, VelaLabs – A Tentamus Company

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK